NOTE: This order is nonprecedential. United States Court of Appeals
for the Federal Circuit
DR. FALK PHARMA GMBH,
Appellant
v.
GENERICO, LLC, FLAT LINE CAPITAL LLC,
MYLAN PHARMACEUTICALS INC.,
Appellees
2017-2312
Appeals from the United States Patent and Trademark Office, Patent Trial and Appeal Board in Nos. IPR2016-00297, IPR2016-01386, IPR2016-01409.
SALIX PHARMACEUTICALS, INC., DR. FALK
PHARMA GMBH,
Plaintiffs-Appellants
v.
MYLAN PHARMACEUTICALS INC., MYLAN INC.,
Defendants-Appellees
2017-2636, 2018-1320
2Appeals from the United States District Court for the Northern District of West Virginia in No. 1:15-cv-00109-IMK, Judge Irene M. Keeley.
VALEANT PHARMACEUTICALS
INTERNATIONAL, INC., SALIX
PHARMACEUTICALS, INC., PROGENICS
PHARMACEUTICALS, INC., WYETH LLC, FKA
WYETH,
Plaintiffs-Appellees
v.
MYLAN PHARMACEUTICALS INC., MYLAN INC.,
MYLAN LABORATORIES LIMITED,
Defendants-Appellants
ACTAVIS LLC,
Defendant
2018-2097
Appeal from the United States District Court for the District of New Jersey in Nos. 2:15-cv-08180-SRC-CLW, 2:15-cv-08353-SRC-CLW, 2:16-cv-00035-SRC-CLW, 2:16-cv-00889-SRC-CLW, 2:17-cv-06714-SRC-CLW, Judge Stanley R. Chesler.
SUA SPONTE
3Before LOURIE, O’MALLEY, and REYNA, Circuit Judges.
O R D E R
Before the court is the movants’ responses to this court’s order to show cause. The movants agree that the court’s precedential order may be unsealed and that no redactions are necessary.
Accordingly,
IT IS ORDERED THAT:
The precedential order issued under seal on February 8, 2019 is hereby unsealed.
FOR THE COURT
February 20, 2019 /s/ Peter R. Marksteiner
Date Peter R. Marksteiner Clerk of Court .